FDA advisory panel recommends Pfizer Covid-19 vaccine be authorized for children
An advisory panel to the Food and Drug Administration voted in favor of authorizing the Covid-19 vaccine made by Pfizer and BioNTech for children between the ages of 5 and 11.
After sometimes tense deliberations that weighed the benefits of vaccination against potential risks, the Vaccines and Related Biological Products Advisory Committee voted 17 to 0 with one abstention on Tuesday that two 10 microgram-doses of the vaccine should be granted emergency use authorization, a clearance that will remain in effect only as long as the pandemic is considered a public health emergency.
